Literature DB >> 12584426

Non-drug therapies for dementia: an overview of the current situation with regard to proof of effectiveness.

Elmar Gräsel1, Jens Wiltfang, Johannes Kornhuber.   

Abstract

An overview will be presented of music therapy, art therapy, movement therapy and reminiscence therapy, memory training, reality orientation, validation therapy, self-maintenance therapy, behaviour therapy, milieu therapy and staff training. The overview will examine the aims of each, the principles on which procedures are based and the proof of their effectiveness. The principal aim of non-drug therapies is to influence symptomatic dementia beneficially and to improve the abilities remaining to the patient. The potential benefits are usually deduced from studies made without control groups. At the present time, proof of the effectiveness of these therapies is still lacking as controlled, randomized studies have yet to be conducted, and so a fundamental evaluation of the therapeutic benefits of non-drug therapies in the treatment of dementia cannot yet be made. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2003        PMID: 12584426     DOI: 10.1159/000068477

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  17 in total

1.  Treatments for Depression in Older Persons with Dementia.

Authors:  Zvi D Gellis; Kimberly P McClive-Reed; Ellen Brown
Journal:  Ann Longterm Care       Date:  2009-02-02

2.  Effects of a creative expression intervention on emotions, communication, and quality of life in persons with dementia.

Authors:  Lorraine J Phillips; Stephanie A Reid-Arndt; Youngju Pak
Journal:  Nurs Res       Date:  2010 Nov-Dec       Impact factor: 2.381

3.  Counselling for dementia caregivers-predictors for utilization and expected quality from a family caregiver's point of view.

Authors:  Elmar Gräßel; Katharina Luttenberger; Angelika Trilling; Carolin Donath
Journal:  Eur J Ageing       Date:  2010-07-14

4.  Memory banking: a life story intervention for aging preparation and mental health promotion.

Authors:  Faika Zanjani; Brian G Downer; Amy F Hosier; John D Watkins
Journal:  J Aging Health       Date:  2014-09-19

5.  Support groups for dementia caregivers--predictors for utilisation and expected quality from a family caregiver's point of view: a questionnaire survey part I*.

Authors:  Elmar Grässel; Angelika Trilling; Carolin Donath; Katharina Luttenberger
Journal:  BMC Health Serv Res       Date:  2010-07-28       Impact factor: 2.655

6.  Why is it so difficult to evaluate nursing interventions in dementia?

Authors:  Christoph Schwarzbach; Hans Förstl; Marc Nocon; Thomas Mittendorf
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2012-04-14

7.  Who would benefit from memory training? A pilot study examining the ceiling effect of concurrent cognitive stimulation.

Authors:  Timothy C Y Kwok; Wai Wang Chau; Kenneth S L Yuen; Anita Y M Wong; Jessie C Y Li; Rebecca Y Y Shiu; Florence K Y Ho
Journal:  Clin Interv Aging       Date:  2011-03-25       Impact factor: 4.458

8.  Day care for dementia patients from a family caregiver's point of view: a questionnaire study on expected quality and predictors of utilisation - Part II.

Authors:  Carolin Donath; Angelika Winkler; Elmar Graessel; Katharina Luttenberger
Journal:  BMC Health Serv Res       Date:  2011-04-13       Impact factor: 2.655

9.  Non-pharmacological, multicomponent group therapy in patients with degenerative dementia: a 12-month randomizied, controlled trial.

Authors:  Elmar Graessel; Renate Stemmer; Birgit Eichenseer; Sabine Pickel; Carolin Donath; Johannes Kornhuber; Katharina Luttenberger
Journal:  BMC Med       Date:  2011-12-01       Impact factor: 8.775

10.  Are the effects of a non-drug multimodal activation therapy of dementia sustainable? Follow-up study 10 months after completion of a randomised controlled trial.

Authors:  Katharina Luttenberger; Benjamin Hofner; Elmar Graessel
Journal:  BMC Neurol       Date:  2012-12-05       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.